N-Acetylglutamate Synthase Deficiency Market Size Projection to 2030

N-acetylglutamate synthetase (NAGS) deficiency is a rare type of genetic disorder that is typically characterized by complete or partial lack of the enzyme N-acetylglutamate synthetase. Excess ammonia travels to the CNS through the blood, leading to NAGS deficiency symptoms and physical findings. This synthetase is one of the six enzymes which play a major role in the breakdown and removal of nitrogen from the body. The lack of N-acetylglutamate synthetase (NAGS) enzyme causes excessive accumulation of nitrogen in the form of ammonia in the blood.

N-Acetylglutamate synthase deficiency is a type of rare deficiency which happens in around 1 in 30,000 birth. This deficiency affects female and male equally. This deficiency often go unrecognized, but these disorders are underdiagnosed, making it difficult to access the frequency of urea cycle disorders in the overall population. Neurological symptoms may be life-threatening and include seizures, stupor, and coma.

Data Bridge Market Research analyses a growth rate in the N-acetylglutamate synthase deficiency market in the forecast period 2023-2030. The expected CAGR N-acetylglutamate synthase deficiency market is tend to be around 3.50% in the mentioned forecast period. The market was valued at USD 1.3 billion in 2022, and it would grow upto USD 1.71 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America is dominating the market ue to the presence of high healthcare expenditure and research & development.

Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-n-acetylglutamate-synthase-deficiency-market

Asia-Pacific is considered to grow over the coming years due to increased advancement in the technology as well as growing healthcare expenditure.

Key players operating in the N-acetylglutamate synthase deficiency market include:

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact: 

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Health-Fitness/44455-N-Acetylglutamate-Synthase-Deficiency-Market-Size-Projection-to-2030.html